Buy now: trend is bullish (SMA_5 > SMA_20 > SMA_200) with positive MACD expansion, and fundamentals/news flow are supportive after record Q4 results.
Near-term setup: price (82.39) is just below R1 ~83.25; a quick push through that level can trigger momentum follow-through toward R2 ~85.58.
Sentiment check: options positioning is call-leaning (low put/call OI), and analyst price targets were raised across the board post-earnings.
What could slow it down: RSI(6) ~67 is getting warm (not extreme), so a brief digestion/pullback is possible, but for an impatient buyer the current level is still attractive given the bullish structure.
Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200 (uptrend across short/medium/long timeframes).
Momentum: MACD histogram +0.0348 and expanding → improving upside momentum.
RSI: RSI_6 = 67.32 → strong but not fully overbought; supports continuation but increases odds of a short pause.
Key levels:
Pivot: 79.49 (important line for trend maintenance)
Resistance: 83.25 (R1) then 85.58 (R2)
Support: 75.72 (S1) then 73.39 (S2)
Pattern-based forward view (provided): ~60% chance of -0.25% next day, -2.2% next week, but +19.09% next month (skew suggests near-term chop, better 1-month upside).
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning (OI): Put/Call open interest ratio 0.25 (puts far lower than calls) → bullish/optimistic positioning.
Activity (volume): Put/Call volume ratio 0.0 and reported volume is 0 → limited same-day flow; sentiment read relies more on OI than fresh trading.
Volatility: 30D IV ~40.08 vs historical vol ~31.4 → options are pricing elevated uncertainty; IV percentile ~61 suggests IV is above average but not extreme.
Technical Summary
Sell
5
Buy
9
Positive Catalysts
Record earnings / strong quarter: Q4 2025 record earnings exceeding $412M; EPS hit $6 for the first time (news).
Balance sheet improvement + capital return: paid off all subordinated debt in 2025; repurchased ~1% of shares in Q4 for $77M.
Growth outlook: management expects mid-single-digit loan and deposit growth with continued organic growth initiatives.
Net Income: $108.36M, +14.81% YoY (profitability improving faster than revenue)
EPS: 1.59, +16.91% YoY (strong per-share growth)
Quality/operating actions (news): loan assets grew ~5% despite large CRE payoffs; asset quality described as healthy; debt payoff and buybacks support per-share compounding.
Truist: PT $86 (from $83), Hold (also previously raised to $83 from $80 on 2026-01-09)
Keefe Bruyette: PT $88 (from $82), Outperform
Wall Street pros: improving NIM expectations, better modeled earnings, loan growth improvement, capital flexibility/buybacks.
Wall Street cons: some firms remain Hold/Equal Weight, reflecting concerns about near-term margin pressure and a less “screaming cheap” setup after the move.
Influential/political trading: no recent congress trading data available; no politician/influential buying/selling indicated in provided data.
Wall Street analysts forecast ABCB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ABCB is 84 USD with a low forecast of 82 USD and a high forecast of 87 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast ABCB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ABCB is 84 USD with a low forecast of 82 USD and a high forecast of 87 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 85.940
Low
82
Averages
84
High
87
Current: 85.940
Low
82
Averages
84
High
87
Stephens
Russell Gunther
Equal Weight
maintain
$79 -> $87
AI Analysis
2026-02-02
Reason
Stephens
Russell Gunther
Price Target
$79 -> $87
AI Analysis
2026-02-02
maintain
Equal Weight
Reason
Stephens analyst Russell Gunther raised the firm's price target on Ameris Bancorp to $87 from $79 and keeps an Equal Weight rating on the shares. A higher base net interest margin and reiterated 2026 expense guidance drive the firm's 2026 and 2027 pre-provision net revenue estimates higher by 3.6% and 3.3%, respectively, the analyst tells investors in a post-earnings note.
DA Davidson
Buy
maintain
$90 -> $94
2026-02-02
Reason
DA Davidson
Price Target
$90 -> $94
2026-02-02
maintain
Buy
Reason
DA Davidson raised the firm's price target on Ameris Bancorp to $94 from $90 and keeps a Buy rating on the shares. The company continued to post strong results, with improved net loan growth in Q4 and an outlook for the same in 2026, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ABCB
